Deals 16 Mar 2015 Gleneagle to buy biotech firm for $2m Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Gleneagle Gold announced its intention to exit the resources sector through the back door today, with a proposal to buy a Melbourne-based unlisted biotechnology company for a share package worth $2 million.
